论文部分内容阅读
目的 :观察和分析斯奇康对婴幼儿哮喘的防治效果。方法 :设自身对照组 5 0例 ,肌注斯奇康 ,每次 1ml ,隔日一次 ,12次为一疗程 ,连用三个疗程 ,两疗程之间停药十天 ,用药前及用药后半年分别进行免疫指标检测。结果 :斯奇康防治婴幼儿哮喘总有效率为 94% ,斯奇康治疗前后IgA、CD3、CD4、CD4 CD8比较差异显著 ,IgG及IgM差异无显著性。结论 :斯奇康可提高婴幼儿哮喘患儿的细胞免疫及体液免疫功能 ,具有显著的防治婴幼儿哮喘发作的作用
Objective: To observe and analyze the effect of schiskan on the prevention and treatment of infant asthma. Methods: Set their own control group of 50 patients, intramuscular injection of Qidi Kang, each 1ml, every other day, 12 times for a course of treatment, once every three courses, two courses of withdrawal for ten days before and after medication six months Immune index detection. Results: The total effective rate of prevention and treatment of infant asthma was 54%. The levels of IgA, CD3, CD4 and CD4 CD8 before and after treatment were significantly different, but there was no significant difference between IgG and IgM. Conclusion: Schcondkon can improve the cellular immunity and humoral immunity in infants and young children with asthma, and has a significant effect in preventing and treating infantile asthma attacks